SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$41.45M

FY 2025 · Annual

Net Income

-$39.87M

FY 2025 · Annual

SGP Earnings Waterfall · TTM

NASDAQ:SGP · Revenue to Net Income

No earnings data available.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 12, 2026
10-QQuarterly reportNov 12, 2026
8-KCurrent reportOct 19, 2026
8-KCurrent reportOct 1, 2026
10-QQuarterly reportAug 6, 2026

How much revenue does SGP generate?

SpyGlass Pharma, Inc. Common Stock (SGP) reported $0.00 of revenue in fiscal 2025.

Is SGP profitable?

SpyGlass Pharma, Inc. Common Stock (SGP) reported -$39.87M of net income.